APA-referens (7:e uppl.)

Kristeleit, R., Leary, A., Oaknin, A., Redondo, A., George, A., Chui, S., . . . Mileshkin, L. (2024). PARP inhibition with rucaparib alone followed by combination with atezolizumab. British Journal of Cancer, 131(5), 820. https://doi.org/10.1038/s41416-024-02776-7

Chicago-referens (17:e uppl.)

Kristeleit, Rebecca, et al. "PARP Inhibition with Rucaparib Alone Followed by Combination with Atezolizumab." British Journal of Cancer 131, no. 5 (2024): 820. https://doi.org/10.1038/s41416-024-02776-7.

MLA-referens (9:e uppl.)

Kristeleit, Rebecca, et al. "PARP Inhibition with Rucaparib Alone Followed by Combination with Atezolizumab." British Journal of Cancer, vol. 131, no. 5, 2024, p. 820, https://doi.org/10.1038/s41416-024-02776-7.